Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country.

Debulpaep S, Corbière V, Levy J, Schelstraete P, Vanden Driessche K, Mascart F, Mouchet F.

Front Pediatr. 2019 Jul 18;7:291. doi: 10.3389/fped.2019.00291. eCollection 2019.

2.

Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease : a multicentre prospective study.

Rousseff T, Claeys T, Vande Vijver E, Moes N, Vande Velde S, Schelstraete P, De Bruyne R, Van Winckel M, Van Biervliet S.

Acta Gastroenterol Belg. 2019 Jan-Mar;82(1):27-30.

PMID:
30888750
3.

Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.

De Baets F, De Keyzer L, Van Daele S, Schelstraete P, Van Biervliet S, Van Braeckel E, Thomas M, Wanyama SS.

Pediatr Allergy Immunol. 2018 Nov;29(7):726-731. doi: 10.1111/pai.12953. Epub 2018 Aug 23.

PMID:
29981532
4.

Pulmonary interstitial glycogenosis - A systematic analysis of new cases.

Seidl E, Carlens J, Reu S, Wetzke M, Ley-Zaporozhan J, Brasch F, Wesselak T, Schams A, Rauch D, Schuch L, Kappler M, Schelstraete P, Wolf M, Stehling F, Haarmann E, Borensztajn D, van de Loo M, Rubak S, Lex C, Hinrichs B, Reiter K, Schwerk N, Griese M.

Respir Med. 2018 Jul;140:11-20. doi: 10.1016/j.rmed.2018.05.009. Epub 2018 May 17. Review.

PMID:
29957271
5.

Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey.

Dodémont M, Argudín MA, Willekens J, Vanderhelst E, Pierard D, Miendje Deyi VY, Hanssens L, Franckx H, Schelstraete P, Leroux-Roels I, Nonhoff C, Deplano A, Knoop C, Malfroot A, Denis O.

J Cyst Fibros. 2019 Jan;18(1):86-93. doi: 10.1016/j.jcf.2018.04.008. Epub 2018 May 24.

PMID:
29805051
6.

Establishing the diagnosis of chronic colonization with Pseudomonas aeruginosa of cystic fibrosis patients: Comparison of the European consensus criteria with genotyping of P. aeruginosa isolates.

Jonckheere L, Schelstraete P, Van Simaey L, Van Braeckel E, Willekens J, Van Daele S, De Baets F, Vaneechoutte M.

J Cyst Fibros. 2018 Nov;17(6):729-735. doi: 10.1016/j.jcf.2018.03.004. Epub 2018 Apr 11.

PMID:
29655935
7.

Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.

Forier K, Van Heck V, Carlier M, Van Braeckel E, Van Daele S, De Baets F, Schelstraete P, Haerynck F, Stove V, Van Simaey L, Vaneechoutte M, Verstraete AG.

J Antimicrob Chemother. 2018 Jan 1;73(1):95-101. doi: 10.1093/jac/dkx331.

PMID:
29029070
8.

Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.

Vandekerckhove K, Keyzer M, Cornette J, Coomans I, Pyl F, De Baets F, Schelstraete P, Haerynck F, De Wolf D, Van Daele S, Boone J.

Eur J Pediatr. 2017 Dec;176(12):1689-1696. doi: 10.1007/s00431-017-3024-7. Epub 2017 Sep 30.

PMID:
28965267
9.

When One Rare Disease Hides Another: Kartagener Syndrome Masking FMF.

Hoste L, De Baets F, Van Daele S, Schelstraete P, Boon M, De Bruyne M, Dullaers M, Coppieters F, Haerynck F.

Clin Pediatr (Phila). 2018 Jul;57(8):981-985. doi: 10.1177/0009922817733705. Epub 2017 Sep 27. No abstract available.

PMID:
28952366
10.

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.

Cools P, Ho E, Vranckx K, Schelstraete P, Wurth B, Franckx H, Ieven G, Van Simaey L, Van Daele S, Verhulst S, De Baets F, Vaneechoutte M.

BMC Microbiol. 2016 Jun 24;16(1):122. doi: 10.1186/s12866-016-0736-1. Review.

11.

Evaluation of timing of first vaccination in children after hematopoietic allogeneic stem cell transplantation.

Bauters T, Bordon Cueto De Braem V, Schelstraete P, Van Lancker S, Laureys G, Benoit Y, Dhooge C.

Eur J Oncol Nurs. 2016 Apr;21:212-4. doi: 10.1016/j.ejon.2015.10.006. Epub 2015 Nov 29.

PMID:
26645948
12.

Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients.

Claus BO, Snauwaert S, Haerynck F, Van Daele S, De Baets F, Schelstraete P.

Int J Clin Pharm. 2015 Aug;37(4):555-8. doi: 10.1007/s11096-015-0077-4. Epub 2015 May 23.

PMID:
26001357
13.

Streptococcal pharyngitis in children: to treat or not to treat?

Van Brusselen D, Vlieghe E, Schelstraete P, De Meulder F, Vandeputte C, Garmyn K, Laffut W, Van de Voorde P.

Eur J Pediatr. 2014 Oct;173(10):1275-83. doi: 10.1007/s00431-014-2395-2. Epub 2014 Aug 12. Review.

PMID:
25113742
14.

Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?

Deschaght P, Schelstraete P, Van Simaey L, Vanderkercken M, Raman A, Mahieu L, Van Daele S, De Baets F, Vaneechoutte M.

PLoS One. 2013 Nov 29;8(11):e79010. doi: 10.1371/journal.pone.0079010. eCollection 2013.

15.

Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis.

Haerynck F, Stordeur P, Vandewalle J, Van Coster R, Bordon V, De Baets F, Schelstraete P, Javaux C, Bouvry MR, Fremeaux-Bacchi V, Dehoorne J.

J Clin Immunol. 2013 Nov;33(8):1293-301. doi: 10.1007/s10875-013-9944-8. Epub 2013 Oct 20.

PMID:
24142231
16.

Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients.

De Bel A, De Geyter D, De Schutter I, Mouton C, Wellemans I, Hanssens L, Schelstraete P, Malfroot A, Pierard D.

J Clin Microbiol. 2013 Dec;51(12):4204-6. doi: 10.1128/JCM.02035-13. Epub 2013 Sep 18.

17.

Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.

De Baets F, Schelstraete P, Haerynck F, Van Biervliet S, De Bruyne R, Franckx H, Van Daele S.

Pediatr Pulmonol. 2014 Apr;49(4):414-6. doi: 10.1002/ppul.22864. Epub 2013 Aug 23.

PMID:
24039244
18.

Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.

Haerynck F, Mahachie John JM, Van Steen K, Schelstraete P, Van daele S, Loeys B, Van Thielen M, De Canck I, Nuytinck L, De Baets F.

Hum Immunol. 2013 Dec;74(12):1649-55. doi: 10.1016/j.humimm.2013.08.282. Epub 2013 Aug 29.

PMID:
23994582
19.

Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients.

Haerynck F, Van Steen K, Cattaert T, Loeys B, Van Daele S, Schelstraete P, Claes K, Van Thielen M, De Canck I, Mahachie John JM, De Baets F.

Hum Immunol. 2012 Nov;73(11):1175-83. doi: 10.1016/j.humimm.2012.08.010. Epub 2012 Aug 29.

PMID:
22940091
20.

Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa.

Schelstraete P, Haerynck F, Van daele S, Deseyne S, De Baets F.

J Cyst Fibros. 2013 Jan;12(1):1-8. doi: 10.1016/j.jcf.2012.07.008. Epub 2012 Aug 29. Review.

21.

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

Bauters T, Claus B, Schelstraete P, Robays H, Benoit Y, Dhooge C.

Int J Clin Pharm. 2012 Feb;34(1):13-6. doi: 10.1007/s11096-011-9593-z. Epub 2011 Dec 13.

PMID:
22161495
22.

Anaphylactic shock as a single presentation of Echinococcus cyst.

De Wispelaere L, Vande Velde S, Schelstraete P, Van Renterghem K, Moerman F, Van Biervliet S, Van Winckel M.

Acta Gastroenterol Belg. 2011 Sep;74(3):462-4.

PMID:
22103055
23.

Malacia, inflammation and bronchoalveolar lavage culture in children with persistent respiratory symptoms.

De Baets F, De Schutter I, Aarts C, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Schelstraete P.

Eur Respir J. 2012 Feb;39(2):392-5. doi: 10.1183/09031936.00035111. Epub 2011 Jul 20.

24.

Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients.

Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Lebecque P, Knoop C, Casimir G, Boboli H, Pierart F, Desager K, Vaneechoutte M, De Baets F.

BMC Microbiol. 2010 Sep 24;10:245. doi: 10.1186/1471-2180-10-245.

25.

Pulmonary function in children after surgical and percutaneous closure of atrial septal defect.

Zaqout M, De Baets F, Schelstraete P, Suys B, Panzer J, Francois K, Bove T, Coomans I, De Wolf D.

Pediatr Cardiol. 2010 Nov;31(8):1171-5. doi: 10.1007/s00246-010-9778-6. Epub 2010 Aug 20.

PMID:
20725719
26.

Milk protein and Oil-Red-O staining of alveolar macrophages in chronic respiratory disease of infancy.

De Baets F, Aarts C, Van Daele S, Haerynck F, De Wachter E, De Schutter I, Malfroot A, Schelstraete P.

Pediatr Pulmonol. 2010 Dec;45(12):1213-9. doi: 10.1002/ppul.21310. Epub 2010 Aug 17.

PMID:
20717909
27.

Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients.

Schelstraete P, Deschaght P, Van Simaey L, Van Daele S, Haerynck F, Vaneechoutte M, De Baets F.

J Cyst Fibros. 2010 Mar;9(2):99-103. doi: 10.1016/j.jcf.2009.11.006. Epub 2009 Dec 8.

28.

Disseminated Mycobacterium avium infection in a patient with a novel mutation in the interleukin-12 receptor-beta1 chain.

Haerynck F, Holland SM, Rosenzweig SD, Casanova JL, Schelstraete P, De Baets F.

J Pediatr. 2008 Nov;153(5):721-2. doi: 10.1016/j.jpeds.2008.05.050.

PMID:
18940359
29.

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.

Schelstraete P, Van Daele S, De Boeck K, Proesmans M, Lebecque P, Leclercq-Foucart J, Malfroot A, Vaneechoutte M, De Baets F.

Eur Respir J. 2008 Apr;31(4):822-9. Epub 2007 Dec 19.

30.

Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M.

J Cyst Fibros. 2007 Jan;6(1):75-8. Epub 2006 Jun 21.

31.

Clinical pharmacy and pediatrics: why focus on antibiotics?

Bauters TG, Nguyen BT, Buyle F, Schelstraete P, De Cock P, De Jaeger A, Verrijckt A, Robays H.

Pharm World Sci. 2006 Feb;28(1):3-5. Epub 2006 Jun 4. No abstract available.

PMID:
16752195
32.

Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.

Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, Van Simaey L, Claeys G, Vaneechoutte M, de Baets F.

Eur Respir J. 2005 Mar;25(3):474-81.

33.

Asphyxiating tracheal bronchogenic cyst.

De Baets F, Van Daele S, Schelstraete P, Haerynck F, Vermassen F, Broers C.

Pediatr Pulmonol. 2004 Dec;38(6):488-90.

PMID:
15514990
34.

Neonatal pulmonary interstitial glycogen accumulation disorder.

Smets K, Dhaene K, Schelstraete P, Meersschaut V, Vanhaesebrouck P.

Eur J Pediatr. 2004 Jul;163(7):408-9. Epub 2004 Apr 23. No abstract available.

PMID:
15106004
35.

Use of tissue type plasminogen activator in neonates: case reports and review of the literature.

Smets K, Vanhaesebrouck P, Voet D, Schelstraete P, Govaert P.

Am J Perinatol. 1996 May;13(4):217-22. Review.

PMID:
8724722

Supplemental Content

Loading ...
Support Center